Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

KKR & Co LP To Invest About $150 Million In Gland Pharma Ltd-Reuters

Friday, 11 Oct 2013 02:39am EDT 

Reuters reported that KKR & Co LP will pay about $150 million for close to 30% of India's Gland Pharma Ltd. A deal is likely to be announced in the coming weeks, one of the sources said on Friday. 

Company Quote

0.18 +0.79%
1:02pm EDT